PharmNXT Biotech’s Post

Another successful Novel Nasal Summit has come to a close! It was great to discuss the latest innovations in nasal drug delivery with fellow industry leaders. These discussions are critical in advancing the industry. If you're looking to partner or collaborate on nasal delivery projects, or have any questions, feel free to message either me or Dontae Solomon to set up a meeting. We look forward to connecting with you and providing solutions. #nasaldelivery #drugdelivery #innovation #catalent

💡 Breaking New Ground in Biopharma: ReSync Bio Raises Fresh Funding 💡 ReSync Bio, a San Francisco-based scientific software company, has secured new funding from Caffeinated Capital, Atria Ventures, and angel investors like Ramsey Homsany (co-founder of Octant Bio)! 💰 🔬 What does ReSync Bio do? Led by CEO Mihir Trivedi, ReSync Bio provides a SaaS platform designed to accelerate drug discovery for biopharma companies. By serving as a single source for preclinical data, the platform automates coordination between labs and CROs, allowing teams to bring drugs to the clinic more efficiently. 💊 🔑 Key features include: • Controlled data permissioning to protect IP 🔒 • Enhanced collaboration across in-house and external teams 🤝 • Streamlined R&D operations from labs to clinics 🧬 This new funding will support key hires and the commercialization of their platform, which is now available for companies and academics! 💻 The future of drug discovery is faster, smarter, and more connected with ReSync Bio. 📢 Stay tuned to Future Techly for the latest updates on this groundbreaking initiative and the latest in tech and business! 💥 Source: FinSMEs #Biopharma #DrugDiscovery #SaaS #R&D #Innovation #PreclinicalResearch #FutureTechly

If you want to have a good talk over health tech, the future of pharma, and digital solutions in medicine and you also attend Latitude59 or you live in Tallinn drop a line here or in the event app! I'll be there representing our company, Targenta Ltd. But what is Targenta?... 👉 Our why In the last decade, medical services have diversified, involving both public and private sectors. However, this diversification has led to challenges due to the lack of integration and coordination among services, as patients often use a mix of private and public facilities, and communication between their different physicians and pharmacists is not guaranteed. The frequent failure to establish secure and seamless intra- and inter-organization communication channels has resulted in medical professionals unintentionally neglecting each other's insights. This lack of collaboration has given rise to conflicting treatment and medication plans, creating a complex web of challenges for patients. Prescribing medications without a shared understanding of a patient's case among different physicians can be highly dangerous. The widely prevalent fragmented healthcare raises the risk of adverse drug interactions, duplicate prescriptions, and conflicting treatment plans, posing serious health threats. Without a comprehensive view of the patient's medical history, there's a heightened potential for unintended side effects, compromised efficacy, and overall confusion in managing the patient's health. 👉 Our Solutions for Healthcare Challenges At Targenta, we've engineered a suite of innovative solutions to address the complex challenges facing medical professionals today. Our Tailored Treatment Options provide personalized diagnostic and therapeutic recommendations, streamlining decision-making and reducing case-specific research times by approximately 20%. With the Medical Team Dashboard System, healthcare providers gain secure, remote collaboration capabilities, enhancing overall patient care effectiveness and cutting administrative costs. Additionally, our PharmaSolv system ensures medication safety by analyzing and optimizing schedules, preventing potential drug interactions, and redundant prescriptions. Check out our services here: https://lnkd.in/d_d6vNDm #startup #tallinn #estonia #latitude59 #innovation #businessangels #venturecaptalists #MVP #preseed #healthtech #medtech #digitalhealth #targenta

Bicoll offers unique expertise in plant processing. This can be used for different indications in the discovery of novel chemical entities. Within a few weeks, you can come up with a biologically active compound class binding to your target. The proprietary technology has been successfully proven over the course of 25 years. Learn more about how to enhance and improve your success rate in preclinical development. #biotech #success #pharma #drugdiscovery #biologicallyactive #botechgate #digitalpartnering

Are you attending this year's #BayOConnect event? Don't miss the chance to meet our experts Wafa and Angela, and discuss how we can support you in overcoming regulatory challenges and achieving your goals. #BayOConnect #biotech #regulatoryaffairs #pharmaregulatory #healthcare #medicine

Getting Day 1 at #DPHARM2024 started with an important leadership panel. The topic at hand: “Aligning Innovations to Solve the Big Problems in Clinical Trials in a Resource-Constrained Environement” A couple of notes that stood out: -> An interesting note that R&D pipelines continue its agressive growth despite difficult economic conditions. -> Assets in preclinical stage doubled in the last 10 years -> We need to start doing things that are more innovative, more patient-centric. Small innovations give us 1-3 percent of improvement and that’s what we need. -> There’s a dichotomy right now in funding following a difficult 2023 in Biotech espeically. There’s a more measured approach than maybe ever before. -> In order to change the way we are working, it is going to require an investment. Time, people, and money. That’s what is required to make change. -> Sites are getting squeezed because of concurrent studies, which is leading to a different type of resource-constrained environment. #DPHARM2024 #DPHARM

With less than a month before #DPHARM2024 and DPHARM Idol Disrupt, we are excited to see Beaconcure, ThoughtSphere, Inspire, Power, ProofPilot , and InSilicoTrials present to this esteemed panel of judges from across the industry to determine which innovation is the greatest leading force for change in how we do clinical trials for 2024. 🔗 Learn more about DPHARM here and the full agenda: DPHARMconference.com #conference #clinicalresearch #clinicaloperations

Pharma Tech & Ingredients 2024 is going nothing short of incredible! 🌍 From groundbreaking innovations to thought-provoking discussions, the event is packed with insights that will shape the future of pharma. The conversations are inspiring, and ideas are thought provoking. I’m walking away with fresh ideas to drive change in this fast-evolving industry. 💡 A huge thank you to all connections, partners and everyone who is making this event memorable! If we didn’t get a chance to connect, feel free to reach out—let’s continue the conversation and have a chance to meet. 🚀 #PharmaTech2024 #PharmaInnovation #FutureOfPharma #Networking #SustainabilityInPharma #pharmatech #pharmatechevent #pharmatechandingredient

Read our latest note 📔 after Diaceutics PLC Capital Markets Day yesterday. This was not an event that set out new targets or strategy but rather served to emphasise the leading position #DXRX occupies in the precision medicine 🏥 ecosystem and therefore confirmed its growth potential. In addition, the CME added colour to the scale of development that has taken place in the capability of the DXRX platform over the last 18 months as well as emphasising the substantial changes in organisation designed to improve the company’s ability to market itself more widely and deeply across the precision medicine opportunity in pharma, biotech, and also life sciences to help find patients and thereby deliver better treatment outcomes. #UKequities #equities #investorrelations #equityresearch #investment #research #LSE

We finally release AutoIND! Our flagship offering reduces the time needed to prepare an IND by 50%. Early partner feedback has been incredible, helping us develop something that truly improves the IND process for pharma and biotech companies. Can't wait for the next steps of our ReALM platform ... #drugdevelopment #healthcareinnovation #artificialintelligence #regulatorycompliance